BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7917844)

  • 1. Rationale for the current surgical management of gastric adenocarcinoma.
    Dalton RR; Eisenberg BL
    Oncology (Williston Park); 1994 Jul; 8(7):99-105; discussion 105-7. PubMed ID: 7917844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
    Le A; Berger D; Lau M; El-Serag HB
    Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total resection of lesser curvature for radical treatment of distal gastric carcinoma.
    Lin ZH; Ma T; Yang K; Li ZM; Liu WC; Wu ZD; Gong JP; Yan Q
    Hepatogastroenterology; 2010; 57(104):1625-30. PubMed ID: 21443132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stage-adapted radical principles in gastric carcinoma].
    Verreet PR
    Praxis (Bern 1994); 1998 Mar; 87(13):447-50. PubMed ID: 9584570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The radical treatment of gastric carcinoma.
    Ranzato R; Fiamingo P; Veroux M; D'Amico DF
    Minerva Chir; 2004 Oct; 59(5):471-7. PubMed ID: 15494674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate.
    Douglass HO; Hundahl SA; Macdonald JS; Khatri VP
    Surg Oncol Clin N Am; 2007 Jan; 16(1):133-55. PubMed ID: 17336241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastrectomy with radical lymphadenectomy--standard therapy of adenocarcinoma of the stomach].
    Thybusch A; Schmid A; Henne-Bruns D; Kremer B
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():173-5. PubMed ID: 9101822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of spleen preservation in patients with gastric cancer.
    Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
    Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential surgical procedure in curative therapy of stomach carcinoma].
    Hermanek P
    Leber Magen Darm; 1996 Mar; 26(2):64, 67-72. PubMed ID: 8684247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is reasonable treatment for gastric adenocarcinoma?
    Sasako M
    J Gastroenterol; 2000; 35 Suppl 12():116-20. PubMed ID: 10779230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.
    Oh SJ; Hyung WJ; Li C; Song J; Kang W; Rha SY; Chung HC; Choi SH; Noh SH;
    J Surg Oncol; 2009 Apr; 99(5):275-80. PubMed ID: 19152367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the management of gastric cancer.
    Karpeh MS; Brennan MF
    Curr Opin Gen Surg; 1994; ():125-30. PubMed ID: 7583945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
    Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
    Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality therapy of gastric cancer.
    Karpeh MS; Kelsen DP
    Surg Oncol Clin N Am; 1997 Oct; 6(4):741-7. PubMed ID: 9309091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.